Key Insights

Highlights

Success Rate

50% trial completion

Treatment Research

3 treatments under study, led by Questionnaire

Research Leaders

7 sponsors active, led by Chinese University of Hong Kong

Related Conditions

Often studied with 4 related conditions

Clinical Risk Assessment

Based on trial outcomes

High Risk

Score: 100/100

Termination Rate

50.0%

1 terminated out of 2 trials

Success Rate

50.0%

-36.6% vs benchmark

Late-Stage Pipeline

0%

0 trials in Phase 3/4

Results Transparency

0%

0 of 1 completed with results

Key Signals

50% success

Data Visualizations

Phase Distribution

1Total
Not Applicable (1)

Trial Status

Terminated1
Completed1

Trial Success Rate

50.0%

Benchmark: 86.6%

Based on 1 completed trials

Clinical Trials (2)

Research Network

Common Treatments

  • Questionnaire1
  • Treatment Chinese Herbal Formula X1
  • Detection Of Antianisakis And Antifish Antibodies1

Active Sponsors

  • Chinese University of Hong Kong1
  • Institut Pasteur de Lille1
  • Hong Kong Sanatorium & Hospital1
  • ANSES1
  • Hôpital Cochin1

Top Investigators

Related Conditions

  • Allergy To Crab1
  • Allergy To Shrimp1
  • Allergy1
  • Anisakis1

Activity Timeline